SOST and breast carcinoma: Treatment of bone marrow derived mesenchymal stem cells and MC3T3 cells with conditioned media from MDA-231 breast cancer cells suppressed osteoblast differentiation, while conditioned media pretreated with anti-sclerostin antibody attenuated the suppression of differentiation [57].